Internal Medicine, Hematology & Oncology · Little Rock, AR
NPI
1902284326
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
8901 Carti Way
Little Rock, AR, 72205
Phone (501) 906-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
134,957 services
Medicare patients, 2024
915
Average age 74
Drug cost, 2024
$5.9M
2,692 prescriptions
Company payments, 2025
$20.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew Briggler was code J9271 (injection, pembrolizumab, 1 mg), 16,000 times for 32 patients. In total Andrew Briggler billed 134,957 services in 190 codes, and Medicare paid $2.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 16,000 | 32 | $44.77 | $716K |
| J0897 Injection, denosumab, 1 mg | Office | 6,360 | 28 | $20.43 | $130K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,724 | 19 | $0.08 | $457 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 5,236 | 38 | $6.20 | $32K |
| J0185 Injection, aprepitant, 1 mg | Office | 4,290 | 19 | $1.33 | $5,718 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,915 | 104 | $0.09 | $260 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,300 | 22 | $15.52 | $36K |
| 85025 Blood Count | Office | 1,627 | 495 | $7.56 | $12K |
| 36415 Venipuncture Blood Collection | Office | 1,535 | 477 | $8.63 | $13K |
| 80053 Clinical Chemistry | Office | 1,351 | 487 | $10.30 | $14K |
| J9041 Injection, bortezomib, 0.1 mg | Office | 1,260 | 11 | $1.47 | $1,850 |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 1,220 | 11 | $31.97 | $39K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,220 | 47 | $0.75 | $915 |
| 83615 Clinical Chemistry | Office | 1,195 | 480 | $5.89 | $7,043 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,050 | 65 | $0.24 | $253 |
By year: 2022 $2.3M for 183,544 services; 2023 $2.1M for 128,429 services; 2024 $2.7M for 134,957 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,627 | 495 | $7.56 | $12K |
| 36415 Venipuncture Blood Collection | 1,535 | 477 | $8.63 | $13K |
| 80053 Clinical Chemistry | 1,351 | 487 | $10.30 | $14K |
| 83615 Clinical Chemistry | 1,195 | 480 | $5.89 | $7,043 |
| 82784 Immunoassay | 891 | 173 | $9.03 | $8,048 |
| 88185 Surgical Pathology Examination | 805 | 32 | $15.76 | $13K |
| 82728 Clinical Chemistry | 484 | 257 | $13.31 | $6,441 |
| 83540 Clinical Chemistry | 396 | 221 | $6.34 | $2,511 |
| 83550 Clinical Chemistry | 396 | 221 | $8.57 | $3,394 |
| 83883 Clinical Chemistry | 218 | 130 | $13.32 | $2,904 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew Briggler prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 169 prescriptions and refills. In total Andrew Briggler wrote 2,692 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 169 | 169 | 42 | $3,900 |
| Eliquis Apixaban | 104 | 111 | 25 | $64K |
| Dexamethasone Generic | 103 | 113 | 48 | $1,997 |
| Oxycodone Hcl Generic | 97 | 97 | 36 | $1,431 |
| Acyclovir Generic | 92 | 131 | 20 | $1,334 |
| Procrit Epoetin Alfa | 88 | 89 | 23 | $218K |
| Prochlorperazine Maleate Generic | 85 | 86 | 47 | $1,547 |
| Xarelto Rivaroxaban | 77 | 99 | 11 | $46K |
| Ondansetron Odt Ondansetron | 74 | 74 | 41 | $3,596 |
| Pantoprazole Sodium Generic | 72 | 126 | 27 | $643 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 64 | 64 | Under 11 | $609K |
| Xgeva Denosumab | 63 | 70 | 15 | $197K |
| Levothyroxine Sodium Generic | 60 | 87 | 13 | $342 |
| Gabapentin Generic | 58 | 63 | 22 | $792 |
| Hydroxyurea Generic | 56 | 89 | 13 | $895 |
Brand drugs: 841 claims; generic drugs: 1,851 claims; opioid claims: 338.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew Briggler $20.99 ($20.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Verity Pharmaceuticals Inc. with $20.99.
| Company | Payments | Amount |
|---|---|---|
| Verity Pharmaceuticals Inc. | 1 | $20.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.